IMPORTANT DATES
-
Abstract Submission opens:
30 November, 2025
-
Abstract Submission Deadline:
25 March, 2026
-
Standard Registration opens:
30 November, 2025
-
Standard Registration Deadline:
05 April, 2026
Session # 01: Common Diseases of
Gastro Intestinal Tract
Sub-Session 1: Navigating
the evolving landscape of GERD: From pathophysiology to precision therapy.
Sub-Session 2: Innovation
and balance: Latest insights and clinical applications of acid-suppressive
therapies.
Sub-Session 3: Innovative
approaches in functional dyspepsia: From mechanisms to multimodal management.
Sub-Session 4: Diagnostic
and therapeutic approaches to refractory functional gastrointestinal symptoms.
Session # 02: Gastro Intestinal
Endoscopy
Sub-Session 1: Precision
diagnostics in upper GI endoscopy: The role of artificial intelligence.
Sub-Session 2: Clinical
practice guidelines for upper GI endoscopy: Case based learning.
Sub-Session 3: Advancing
therapeutic endoscopy techniques.
Sub-Session 4: Recent
updates in the endoscopic diagnosis and management of pancreatic cysts.
Session # 03: Pancreatitis
Sub-Session 1: Autoimmune pancreatitis: Cornerstones and future perspectives.
Sub-Session 2: Managing complications of chronic pancreatitis: a guide for the gastroenterologist.
Sub-Session 3: The interaction of microbiome and pancreas in acute pancreatitis.
Sub-Session 4: Groove pancreatitis: from enigma to future directions.
Session # 04: Bowel Disorders
Sub-Session 1: Advancing IBD
care: Translating research into clinical practice.
Sub-Session 2: Innovations
in endoscopic management of IBD.
Sub-Session 3: Comprehensive
strategies in IBS management: From pathophysiology to practice.
Sub-Session 4: Emerging trends
in constipation treatment: From microbiota to modern therapeutics.
Session # 05: Colonoscopy
Sub-Session 1: Latest
advances in diagnostic and therapeutic colonoscopy for challenging situations.
Sub-Session 2: Adverse
events related to colonoscopy: Global trends and future challenges.
Sub-Session 3: Optimization
of colonoscopy quality: Comprehensive review of the literature and future
perspectives.
Sub-Session 4: AI for
colonoscopy and intestinal diseases: The road ahead.
Session # 06: Liver Disorders
Sub-Session 1: Special
considerations for liver diseases in distinct conditions.
Sub-Session 2: Biomarkers
for diagnosis, treatment response, and prognosis in liver diseases.
Sub-Session 3: Guidelines
and evidence-based recommendations in liver disease management.
Sub-Session 4: Early
predictors of hepatitis B relapse after antiviral cessation.
Session # 07: Gastro Intestinal
Tract Cancer
Sub-Session 1: Novel
biomarkers and strategies in early diagnosis of gastrointestinal cancers.
Sub-Session 2: Pancreatic
ductal adenocarcinoma: Insights from genomics to clinical implications.
Sub-Session 3: Focused
management strategies in gastrointestinal cancer.
Sub-Session 4: Innovative
strategies in gastroesophageal cancer therapy: Precision medicine, resistance,
and emerging technologies.
Session # 08: ERCP
Sub-Session 1: Ensuring
safety and effectiveness in ERCP: Case-based approaches with technical
insights.
Sub-Session 2: ERCP in the
management of biliary complications after cholecystectomy.
Sub-Session 3: Clinical
practice guideline for post-ERCP pancreatitis.
Sub-Session 4: Current
challenges in pediatric ERCP.
Session # 09: Gastrointestinal
Bleeding
Sub-Session 1: Managing
antiplatelet and anticoagulation: Therapy in the peri-endoscopic period.
Sub-Session 2: Management of
nonvariceal upper GI bleeding: Choosing the right tool.
Sub-Session 3: Lower GI
bleeding: Role of the endoscopist and a treatment algorithm.
Sub-Session 4: Investigating
and managing small bowel bleeding.
Session # 10: Gastroduodenal
Diseases
Sub-Session 1: Autoimmune
gastritis, eosinophilic gastroduodenitis: New advances in diagnosis and therapy.
Sub-Session 2: The evolution
of gastroparesis as a sensorimotor disorder: It's on the spectrum.
Sub-Session 3: Artificial
nutrition support in disorders of gut-brain interaction: What, when, why not?
Sub-Session 4: Complex case
discussion.
Session # 11: Colorectal Cancer
Sub-Session 1: Exploring the
latest advances in colorectal cancer prevention and screening.
Sub-Session 2: Optimal
treatment strategies for rectal cancer.
Sub-Session 3: Current
insights and future directions in colorectal neoplasia: Pathogenesis, detection
and therapy.
Sub-Session 4: Genetic and
biological hallmarks of colorectal cancer.
Session # 12: Peptic Ulcer
Disease
Sub-Session 1: The shifting
etiology of PUD: Moving beyond H. pylori and NSAIDs to include idiopathic
ulcers.
Sub-Session 2: Global trends
in PUD burden: Analyzing declining prevalence alongside rising complications in
specific regions
Sub-Session 3: Confronting
antimicrobial resistance: Updated, effective, and evidence-based quad therapy
for H. pylori eradication.
Sub-Session 4: Management of refractory PUD: Treatment approaches for ulcers that fail to heal after standard therapy.
Attendee Criteria
Attendance is generally limited to active researchers and authors of accepted abstracts. Authors of accepted abstracts are pre-approved for registration. All other researchers must Sign up and register towards the conference.
A very limited number of spots are available for individuals in Keynote/Plenary positions. Some of the Keynote and Plenary Speakers will have an opportunity to chair any session during the conference.
25 Oral presentation spots are available for 2-day events. The individual speaker is allowed to present a maximum of 2 talks at the conference.
Who Can Attend
Researcher/Academic /Industrial / Clinical / Private / Marketing
Researchers actively participating in basic science investigations, clinical studies, or epidemiologic research.
Physicians & Scientists who have faculty appointments at academic institutions including medical school programs, or practitioners who are involved in patient care or counselling.
Industries related to pharmaceuticals, Manufacturing, Services, Clinical can achieve visibility and credibility, exhibiting at a trade show has hundreds of benefits for your business. Establishing a presence, whether big or small, for your company at an exhibition gives you a powerful platform for meeting new customers, reaching out to your existing clients, and building a more established and reliable brand.
Clinical takes advantage of the educational and networking opportunities designed for hospital professional.
Marketers from generating new business to staying current with the latest trends, attending marketing events, meetings, and conferences can be crucial to the success of a company’s or individual’s growth strategy. There are some key benefits for why marketers should consider attending networking events.
1. Build Meaningful Relationships
2. Stay Current with Trends by Learning from Powerful Speakers
3. Connect with Influencers and in Turn, You’re Target Audience
4. Get Fresh Ideas and Solutions for Your Business.
Various sessions in our Conferences:
Plenary Talk: A plenary talk of a conference which all members of all parties are to attend. Such a session may include a broad range of content, from keynotes to panel discussions, and is not necessarily related to a specific style of presentation or deliberative process.
Keynote: This is a talk on a specific theme which represent the whole subject of the conference. Keynotes are usually delivered by Professors, President of associations, MD and above.
Oral Presentation: A presentation is a process of presenting a topic to an audience. It is typically a demonstration, introduction, lecture, or speech meant to inform, persuade, inspire, motivate, or to build goodwill or to present a new idea or product.
Delegate: One who gains knowledge, comprehension or mastery through experience or study; someone who learns or takes knowledge or beliefs; one that is learning; one that is acquiring new knowledge, behaviour’s, skills, values or preferences.
Poster Presentation: A poster presentation, at a congress or conference with an academic or professional focus, is the presentation of research information, usually peer-reviewed work, in the form of a poster that conference participants may view. A poster session is an event at which many such posters are presented.
Workshop: A workshop is designed to teach something or develop a specific skill while an academic conference is about presenting original research and getting feedback from peers. A workshop doesn't necessarily have to present original research; it is directed more towards teaching and learning in an interactive environment.
E-poster: An e-Poster or digital poster is a digital presentation of research that is presented within a congress.
Video Presentation: Animated or recorded video describing a research or review topic. Video talks for usually not more than 20-30mins)



.png)